Funding · Company
NextPoint Therapeutics, Inc.
Cambridge, MABiotech & Pharma
NextPoint Therapeutics, Inc. of Cambridge, MA has disclosed $156M across 3 Form D offerings filed with the SEC between Dec 27, 2022 and Jul 30, 2026.
$156M
Total disclosed
3
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$34M
Form D · Jul 30, 2026 ↗
Q3 2026
· target $49M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001959209Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →